Moderna’s COVID-19 vaccine moves into late-stage trial

Moderna Inc said on Monday it had started a late-stage trial to test the effectiveness of its COVID-19 vaccine candidate, the first such study under the Trump administration's program to speed development of measures against the novel coronavirus. Read More

from Canoe https://ift.tt/2CTksjt